Incannex Healthcare Inc. (NASDAQ: IXHL)
$2.57
+0.0200 ( +0.78% ) 28.1K
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
Market Data
Open
$2.57
Previous close
$2.55
Volume
28.1K
Market cap
$44.81M
Day range
$2.39 - $2.67
52 week range
$0.80 - $12.68
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 292 | Oct 05, 2023 |
6-k | Quarterly Reports | 3 | Sep 08, 2023 |
6-k | Quarterly Reports | 2 | Sep 01, 2023 |
6-k | Quarterly Reports | 14 | Sep 01, 2023 |
6-k | Quarterly Reports | 3 | Aug 24, 2023 |
6-k | Quarterly Reports | 3 | Aug 22, 2023 |
6-k | Quarterly Reports | 3 | Aug 10, 2023 |
6-k | Quarterly Reports | 3 | Aug 08, 2023 |
6-k | Quarterly Reports | 3 | Aug 01, 2023 |
6-k | Quarterly Reports | 3 | Jul 28, 2023 |